12-11134216-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001097643.2(TAS2R30):c.29C>T(p.Ser10Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000543 in 1,611,958 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001097643.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R30 | NM_001097643.2 | c.29C>T | p.Ser10Phe | missense_variant | 1/1 | ENST00000539585.1 | NP_001091112.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R30 | ENST00000539585.1 | c.29C>T | p.Ser10Phe | missense_variant | 1/1 | 6 | NM_001097643.2 | ENSP00000444736.1 |
Frequencies
GnomAD3 genomes AF: 0.000612 AC: 93AN: 152082Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000517 AC: 126AN: 243762Hom.: 0 AF XY: 0.000514 AC XY: 68AN XY: 132372
GnomAD4 exome AF: 0.000536 AC: 783AN: 1459876Hom.: 1 Cov.: 38 AF XY: 0.000509 AC XY: 370AN XY: 726208
GnomAD4 genome AF: 0.000612 AC: 93AN: 152082Hom.: 0 Cov.: 33 AF XY: 0.000673 AC XY: 50AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.29C>T (p.S10F) alteration is located in exon 1 (coding exon 1) of the TAS2R30 gene. This alteration results from a C to T substitution at nucleotide position 29, causing the serine (S) at amino acid position 10 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at